SOPHiA GENETICS Investor Relations Material
Latest events
Q1 2025
SOPHiA GENETICS
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from SOPHiA GENETICS SA
Access all reports
Segment Data
Access more data
Revenue by
Business area
SOPHiA Platform
Workflow equipment and services
Expenses by
Financials
SOPHiA GENETICS SA engages in the research and development, services, equipment, and other business related to diagnostic data management. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform is used by hospital and laboratory worldwide.
Key slides for SOPHiA GENETICS SA
Q4 2024
SOPHiA GENETICS SA
Q1 2025
SOPHiA GENETICS SA
Latest articles
)
Figma: Collaborative Design Tool Ready for IPO
Figma, the popular design platform, is preparing for a potential IPO in 2025 as it continues to reshape the future of collaborative design.
22 May 2025
)
Companies That Had Their IPO in 2024: Momentum Increasing
2024 marked a steady year for IPOs, driven by strong markets, AI momentum, and high-profile listings across industries and regions.
22 May 2025
)
The Rise and Fall of Wirecard
A look inside the Wirecard scandal, which took the company from the prestigious DAX 30 to insolvency through the largest accounting fraud in European history.
16 May 2025
Ticker symbol
SOPH
Country
🇺🇸 United States